Millions of people across the UK are living with hepatitis B without having any idea they carry the virus.
Because the infection often develops quietly over years without causing noticeable symptoms, it’s remarkably easy for people to pass it on or suffer long-term liver damage before anything seems wrong. Far from being a rare or distant health issue, it’s a growing public health concern sitting right under the radar. Here’s why so many cases are going undiagnosed, the subtle signs you shouldn’t ignore, and how getting tested can save your life.
What chronic hepatitis B actually is
Chronic hepatitis B is a long-term infection of the liver caused by the hepatitis B virus. Left unmanaged, it can gradually lead to serious liver damage, including scarring known as cirrhosis, and significantly raises the risk of liver cancer down the line.
The virus spreads through contact with infected blood and other bodily fluids. What makes it particularly tricky is that most people don’t experience any symptoms when they’re first infected, which means the condition can sit undetected in someone’s body for years, sometimes even decades, before it’s ever picked up.
How many people does the condition affect?
Globally, roughly 240 million people are living with chronic hepatitis B. Despite that huge number, international health bodies have said that efforts to bring the condition under control worldwide are currently falling behind schedule.
That’s a striking gap considering the tools to deal with it, vaccination, testing and effective treatment, already exist and are well established. The issue isn’t a lack of solutions, it’s that those solutions aren’t reaching enough people quickly enough.
Why so few people actually know about it
A recent global survey of thousands of adults found that more than eight in 10 either knew very little about chronic hepatitis B or hadn’t heard of it at all. That’s not a small awareness gap, it’s a fairly enormous one for a condition affecting hundreds of millions of people worldwide.
The confusion goes beyond simply not recognising the name, either. Plenty of people surveyed weren’t clear on how the virus is actually prevented, whether treatment exists, or what kind of long-term impact it can have on someone’s health if left unaddressed.
It poses a cancer risk that’s flying under the radar.
Perhaps the most surprising finding is how differently chronic hepatitis B is perceived compared to what’s actually known about it medically. It’s estimated to be responsible for roughly half of all liver cancer cases worldwide, yet only around one in three people surveyed considered it a high risk factor for cancer at all.
By comparison, far more people instinctively linked cancer risk to things like smoking, drinking, obesity or air pollution. Even among people who were aware of some connection between hepatitis B and liver cancer, most significantly underestimated just how big that link actually is.
Low awareness sadly leads to fewer people getting tested.
It’s not just knowledge that suffers when a condition stays under the radar, it’s behaviour too. Around three in four adults surveyed said they’d never been tested for hepatitis B in their life.
Interestingly, among people who’d never been tested, the main reason wasn’t refusal or fear, it was simply never having thought about it, or not believing they were personally at risk. When something rarely comes up in everyday conversation, it becomes much harder for people to see how it might actually apply to them.
Visibility matters just as much as medicine.
What makes this particularly frustrating is that chronic hepatitis B isn’t some mysterious, unmanageable condition. Vaccination, testing, and treatment are all well established and have been for years, yet outcomes globally still aren’t improving at anywhere near the pace they should be.
Much of the ongoing gap isn’t about whether the right tools exist, it’s about how consistently they’re actually used, and how much priority health systems and policymakers give the condition. Closing that gap partly comes down to making hepatitis B feel more relevant and visible in people’s everyday lives, rather than something that only gets discussed in a clinical setting.
Talking about it matters more than people realise.
Breaking down the silence around chronic hepatitis B starts with something surprisingly simple: talking about it more openly. Understanding whether testing might be relevant to you, and knowing the basics of how the virus spreads and how to protect yourself and others, is a meaningful first step that costs nothing and takes very little time.
When a health condition becomes part of normal, everyday conversation, it becomes far easier for people to recognise when it might actually apply to them. Given how many people are living with chronic hepatitis B without knowing it, that change in awareness could end up mattering just as much as any medical advance.
